Delivery Order SPE2DB24D2205-SPE2DB25FDUEF

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $87,945.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $18,265.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a completion date of September 13, 2024. This is a firm-fixed-price delivery order contract, which indicates that Amerisourcebergen will provide the specified medical product at a predetermined price. Amerisourcebergen is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $348,555.25 Firm Fixed Price Delivery Order contract is for the provision of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a completion date of July 19, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award, valued at $11,255.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2025 and is a firm fixed-price contract. The award is not designated as a set-aside contract, indicating open competition....
This federal contract award is a delivery order valued at $37,825.20 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with an ultimate completion date of May 28, 2025. The contract is a firm fixed-price arrangement and is not set aside for any particular business type. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,431.90, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a performance period ending on April 8, 2025. The...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,224.50 firm fixed-price delivery order is for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with a completion date of June 10, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which allows Amerisourcebergen to supply a wide range of...
This federal contract award, valued at $1,826.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The specific item being procured is MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a...
This federal contract award, valued at $18,353.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with a performance period ending on August 11, 2023. The contract has a Firm Fixed Price pricing type and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a for-profit...
This federal contract award, valued at $3,044.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award was for the delivery of "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML", a pharmaceutical product, with a completion date of May 22, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDUEF
    Delivery Order

This federal contract award, valued at $18,889.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order covers the provision of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, to be delivered by November 18, 2024. The contract was awarded on a Firm Fixed Price basis and was not designated under any set-aside program, indicating open competition. Amerisourcebergen is the prime contractor, and the contract supports the DLA's medical supply and healthcare programs for military personnel, veterans, and other federal beneficiaries.

Generated 2/14/25, 9:16 AM